by Lara De Meo Hoyt | Feb 3, 2021 | News
The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
by RGHI | Feb 2, 2021 | News
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.
by RGHI | Jan 29, 2021 | News
In an interview about the efficacy of COVID-19 vaccines, institute director Richard Marlink responds to public opinion about the differences among vaccines that are authorized or in the pipeline for use in the United States.
by RGHI | Jan 28, 2021 | News
Racial disparities in COVID-19 mortality in the U.S. are associated with social factors like income, education, and internet access, according to a Rutgers study published in the Journal of Racial and Ethnic Health Disparities.
by RGHI | Jan 26, 2021 | News
The global health consequences and moral implications of wealthy countries hoarding vaccines could be quite serious, said institute director Richard Marlink in a story published by The Daily Targum.